Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Keloid Treatment Market: By Type, By End User and Region Forecast 2019-2030
Keloid Treatment Market size was valued at US$ 3620 million in 2023 and is poised to grow at a CAGR of 5.8% from 2024-2030. A keloid is an overgrown scar that rises beyond the skin's surface as a result of the creation of extra scar tissue on the healed skin area following surgery, a burn, or an injury. Keloids are most commonly found on the hands, legs, and neck, but they can appear anywhere. Although the exact cause of keloids is unknown, numerous factors such as age, gender, blood group, type of lesion, anatomical site, number of sites wounded, and family history can all play a role in identifying the cause. Other factors that may contribute to keloid formation and in predicting keloid behaviour during diagnosis or therapy include delayed wound healing and hypertension. Excess of a protein in ones skin during cure process after an injury causes raised scar, which is known as keloid.
Keloid treatment greatly helps to flatten, soften and north america stretch and shrink film the keloid as they are tough to get rid of entirely. Healthcare experts generally give combination treatment for obtaining high treatment efficiency rates. Keloid scar can reduce over a period. Keloid scars are generally found in people of age group 10-30 years Keloid scar cases are hugely seen in Asian, African as well as American People. Acquisitions, mergers, collaborations and new product introduction are some of the effective strategies followed by the industries of the market in order to strengthen their place in the market. Key players of this market are also bringing new technologies in the market. An abnormal proliferation of a scar tissue which farms at site of cutaneous injury is called as keloid. Keloid scar doesnt regress and progress beyond the scars original margin and it can reduce over a period of time. Keloids are the benign fibroproliferative dermal tumours.
Study Period
2024-2030Base Year
2023CAGR
5.8%Largest Market
North AmericaFastest Growing Market
Asia Pacific
Adoption of technological advancements in derma care, increase in awareness among the people regarding treatment for the keloids expected to fuel the market. Furthermore, lifestyle changes, growing beauty consciousness, rise in personal care expenditure, growing acceptance of the patients to various treatment approaches are the factors which are expected to boost the growth of the market.
However, lack of awareness, adverse effects regarding the treatment, high cost of treatment are major restraints of the market. As per National Institute of Health, Keloid scars are most common in people with age group of 10-30 years. Keloid scars are commonly seen in African Americans, Asians, or Hispanic descents. Growing consciousness regarding appearance and looks among people is the major driving factor for the market.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 3620 million |
Market CAGR |
5.8% |
By Type |
|
By End User |
|
By Region |
|
Download Free Sample Report
The global keloid treatment market size was valued at US$ 3620 million in 2023 and is projected to grow at a CAGR of 5.8% from 2024 to 2030.
Growing Concerns Regarding Aesthetics Appearances
Asia Pacific is the fastest-growing for the market
1. Executive Summary |
2. Global Keloid Treatment Market Introduction |
2.1.Global Keloid Treatment Market - Taxonomy |
2.2.Global Keloid Treatment Market - Definitions |
2.2.1.Type |
2.2.2.End User |
2.2.3.Region |
3. Global Keloid Treatment Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4. Global Keloid Treatment Market Analysis, 2019-2023 and Forecast 2024-2030 |
4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Keloid Treatment Market By Type, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
5.1. Compression Therapy |
5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Intralesional Corticosteroid Injections |
5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Occlusive Dressing |
5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Excision |
5.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Cryosurgery |
5.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
5.6. Laser Therapy |
5.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.6.3. Market Opportunity Analysis |
5.7. Radiation Therapy |
5.7.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.7.3. Market Opportunity Analysis |
5.8. Interferon Therapy |
5.8.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.8.3. Market Opportunity Analysis |
6. Global Keloid Treatment Market By End User, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
6.1. Hospitals |
6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Beauty Centres |
6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Dermatology Clinics |
6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Others |
6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7. Global Keloid Treatment Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia Pacific (APAC) |
7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Middle East and Africa (MEA) |
7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Latin America |
7.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8. North America Keloid Treatment Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
8.1. Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.1.1.Compression Therapy |
8.1.2.Intralesional Corticosteroid Injections |
8.1.3.Occlusive Dressing |
8.1.4.Excision |
8.1.5.Cryosurgery |
8.1.6.Laser Therapy |
8.1.7.Radiation Therapy |
8.1.8.Interferon Therapy |
8.2. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.2.1.Hospitals |
8.2.2.Beauty Centres |
8.2.3.Dermatology Clinics |
8.2.4.Others |
8.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.3.1.United States of America (USA) |
8.3.2.Canada |
9. Europe Keloid Treatment Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
9.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Compression Therapy |
9.1.2.Intralesional Corticosteroid Injections |
9.1.3.Occlusive Dressing |
9.1.4.Excision |
9.1.5.Cryosurgery |
9.1.6.Laser Therapy |
9.1.7.Radiation Therapy |
9.1.8.Interferon Therapy |
9.2. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Hospitals |
9.2.2.Beauty Centres |
9.2.3.Dermatology Clinics |
9.2.4.Others |
9.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Germany |
9.3.2.France |
9.3.3.Italy |
9.3.4.United Kingdom (UK) |
9.3.5.Spain |
9.3.6.Rest of EU |
9.3.7. |
10. Asia Pacific (APAC) Keloid Treatment Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Compression Therapy |
10.1.2.Intralesional Corticosteroid Injections |
10.1.3.Occlusive Dressing |
10.1.4.Excision |
10.1.5.Cryosurgery |
10.1.6.Laser Therapy |
10.1.7.Radiation Therapy |
10.1.8.Interferon Therapy |
10.2. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Hospitals |
10.2.2.Beauty Centres |
10.2.3.Dermatology Clinics |
10.2.4.Others |
10.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.China |
10.3.2.India |
10.3.3.Australia and New Zealand (ANZ) |
10.3.4.Japan |
10.3.5.Rest of APAC |
11. Middle East and Africa (MEA) Keloid Treatment Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Compression Therapy |
11.1.2.Intralesional Corticosteroid Injections |
11.1.3.Occlusive Dressing |
11.1.4.Excision |
11.1.5.Cryosurgery |
11.1.6.Laser Therapy |
11.1.7.Radiation Therapy |
11.1.8.Interferon Therapy |
11.2. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Hospitals |
11.2.2.Beauty Centres |
11.2.3.Dermatology Clinics |
11.2.4.Others |
11.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.GCC Countries |
11.3.2.South Africa |
11.3.3.Rest of MEA |
12. Latin America Keloid Treatment Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Compression Therapy |
12.1.2.Intralesional Corticosteroid Injections |
12.1.3.Occlusive Dressing |
12.1.4.Excision |
12.1.5.Cryosurgery |
12.1.6.Laser Therapy |
12.1.7.Radiation Therapy |
12.1.8.Interferon Therapy |
12.2. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Hospitals |
12.2.2.Beauty Centres |
12.2.3.Dermatology Clinics |
12.2.4.Others |
12.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Brazil |
12.3.2.Mexico |
12.3.3.Rest of LA |
13. Competition Landscape |
13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
13.2.1.GlaxoSmithKline Plc |
13.2.2.Avita Medical |
13.2.3.Pacific World Corporation |
13.2.4.Bristol-Myers Squibb Company |
13.2.5.Renovo Group plc |
13.2.6.Novartis AG |
13.2.7.Valeant Pharmaceuticals International Inc |
13.2.8.RXi Pharmaceuticals |
14. Research Methodology |
15. Appendix and Abbreviations |
Key Market Players